Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.7 |